On the other hand, a significant reduction was observed in NT-pro-BNP values (from 2496.0 (936.0–3687.0) to 2012.0 (280.0–2656.0) pg/mL, p < 0.001), and improvement was observed in clinical symptoms (Kansas City Cardiomyopathy Questionnaire—clinical score (KCCQ-CS) from 60.9 ± 1.4 to 64.6 ± 1.6 pt, p < 0.001). Here, NPPB is linked to cardiomyopathy.